Tolterodine 4 mg: Clinical Trials

1 trial of Tolterodine 4 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Tolterodine 4 mg: new trials by email Literature Review of Tolterodine 4 mg trials Research Report on Tolterodine 4 mg

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity
Tolterodine 4 mg, arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks - Overactive Bladder
Phase 2 / Phase 3CompletedUniversità degli Studi dell'Insubria2004-01-012008-04-01

Conditions studied

Urinary Bladder, Overactive (1)

Sponsors

Università degli Studi dell'Insubria (1)

Countries

Italy (1)

Results publications

PMID 18584946